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Epidermal Langerhans cells are dendritic bone mar-
row-derived cells which synthesize and express Ia an-
tigens. During the past decade, in vitro studies have 
demonstrated that they play a critical role in the induc-
tion of many types of T -cell responses. Specifically, 
Langerhans cells are effective antigen-presenting cells 
in allogeneic and antigen specific proliferative and cy-
totoxic T-cell responses. This paper reviews these func-
tions and suggests areas of future investigations into the 
mechanisms involved in T-cell activation by Langer hans 
cells. 
There is considerable evidence indicating that specially func-
tion ing cells play an essential role in the presentation of anti-
gens to effector lymphocytes in many immune responses such 
as antibody production, antigen- and mitogen-induced T -cell 
proliferation , and cytotoxic T lymphocyte (CTL) induction [1-
12]. Under most circumstances, the cells subserving these func-
tions are Ia positive, non-T- , non -B- cells and are found in 
many organ systems. Although early studies suggested that 
these functions were subserved by Ia positive, glass-adherent 
highly phagocytic macrophages, recent studies suggest that th~ 
functions are not mediated by macrophages but by Ia positive 
dendritic cells [13,14]. Within the epidermis, epidermal Lan-
ge rhans cell s (LC), wh ich are bone marrow-derived and are the 
only cell s (with in normal epidermis) which synthesize and 
express Ia antigens, are critical for these antigen presentation 
functions [ 15]. Although some of the phenotypic characteristics 
of LC and dendritic cells a re identical, several differences exist. 
The relationship between these dendritic cells is reviewed by 
Schuler et al in this issue [16]. 
The focus of this article will be to review some of the 
information which indicates the critical nature of LC in the 
generation of T cell reactivity and to suggest future areas of 
investigation. Many of the functional studies utilizing LC were 
initially performed in guinea pigs, but most recent studies have 
utilized human beings or mice. In agreement with the reports 
of Czern ielewski eta] [17], Morhenn eta] [18], and Bjercke et 
al [19] we have shown that enrichment of epidermal cell sus-
pensions for LC enhances stimulation in a mixed epidermal-
lymphocyte reaction. Enrichment of epidermal ce ll (EC) sus-
pensions for LC has been accomplished utilizing several meth-
ods which take advantage of surface markers present on LC 
which are distinct from keratinocytes and melanocytes. These 
methods include sorting cells via a fluorescence-activated cell 
sorter, density centrifugation after rosetting LC with antibody-
coated red blood cells, "panning" for cells binding OKT6 or 
anti-Ia mouse antibody on culture plates coated with goat 
anti mouse lgG and "panning" of cells on culture plates coated 
with anti- Ia antibodies. Fig 1 demonstrates a representative 
experiment in which human epidermal LC, sensitized with 
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mo1._1se OKT6 antibody, were enriched (by "panning" on goat 
ant1mouse IgG coated plates) from 2% of t he suspension to 
49%. The T-cell response is markedly enhanced relative to 
unfractionated EC or EC depleted of LC by "panning." While 
LC enrichment demonstrates that LC are capable of stimulat-
ing T -cell reactivity, rigorous depletion of LC demonstrates the 
critical dependence of EC upon the presence of LC for T -cell 
stimulatory capacity. In order to deplete human EC suspensions 
of LC to a point where there is virtually no allostimulatory 
capacity remaining, we have found that 2 procedures are often 
required, i.e., "panning" depletion of antibody-coated cells fol-
lowed by lysis. of_ the r~maini~g antibody-coated cells using 
complement. S1mdarly, mcubat10n of EC with a combination 
of both Leu 6 (a complement-fixing antibody which binds the 
same T6 antigen a_s OKT6) and anti-Ia antibodies followed by 
complement lys1s IS more effective at LC depletion than com-
plement lysis following incubation with either antibody alone. 
A co~paris~n of the c~paci~y of LC to perform allostimulatory 
functwns w1th that of penpheral blood mononuclear cells is 
discussed elsewhere in this issue by Sontheimer [20]. 
In addition to allostimulation, it is clear that LC function in 
hapten and soluble protein stimulation of sensitized T cells 
suggesting that they may represent the peripheral-most limb 
of the immune system [15]. LC have also been shown to mediate 
concanavalin A-induced proli feration of purified T cell s as 
efficiently as spleen cell suspensions [21] thus further extend-
ing their accessory cell functional repertoire. 
Recent studies have addressed the question as to whether LC 
can funct ion as !a-positive stimulatory cells in an in vitro 
primary CTL induction system. Using mouse EC, Pehamberger 
et a] [22] and Tsuchida et al [23] have demonstrated that LC 
exhibit potent !a-positive stimulatory function, comparable to 
spleen cells, in both allo-CTL induction and in hapten-modified 
CTL induction. Again, LC are critical for the generation of 
CTL as evidenced by "panning" enrichment and depletion of 
these cells (Fig 2) . In humans, Faure et al [24] have also recently 
demonstrated that LC can act as stimulatory cells in CTL 
induction. 
96s 
An important question to transplantation biologists is 
w?ether antigen-presenting cells which have the ability to 
stimulate both allo-proliferation and allo-CTL induction can 
also present allogeneic class I antigens to self. That is, if one 
depletes an organ from mouse A of allo-stimulatory cells (Ia or 
class II alloantigen bearing antigen-presenting cells) and trans-
plants the organ to mouse B, will the organ from mouse A be 
rejected even if it is repopulated with host (mouse B) antigen-
presentmg cells? Studies utilizing parathyroid glands, skin, and 
pancreas would suggest t hat if alloantigen or allo-CTL stimu-
latory cells are depleted from the donor using various culture 
conditions or chimerized organs, the rate of rejection is mark-
edly prolonged [25,26] . Recently, Faustman et al [27] demon-
strated that treatment of islets of Langerhans from the pan-
cr~as with antidendritic cell antibody (33D1) and complement 
pnor to transplantation significantly prolonged their survival 
in histoincompatable mice. This would suggest that if the 
transplanted organ were repopulated with antigen-presenting 
cells from the host, these cells do not_ function in presenting 
the allogeneic class I antigens. 
In order to address this question in vitro, T suchida et al [23] 
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FI G 1. Effect of "panning" enrichment and depletion of human LC 
on epidermal cell alloantigen presentation. Unfractionated EC suspen-
sions (circles, solid line ) sensit ized wi th Leu-6 antibody were placed on 
Petri dishes coated wi th goat antimouse IgG. Nonadherent EC, par-
tially depleted of LC (triangles, large dashe:; ), were harvested separately 
from cells adherent to the Petri dishes which were highly enriched in 
LC (squares, small dashes) . Each EC population was irradiated, and 
placed in culture at va rying concentrat ions (EC) with 50,000 allogeneic-
responder ce lls for 7 days. [3H]TdR incorporation was used as an index 
of proliferation (CPM). 
determined whether added LC, which were syngeneic to t he 
responder ce lls in a cul ture consisting of responder-T cells and 
allogeneic-stimulator cells depleted of !a-bearing adherent cells, 
could resto re t he CTL response toward a llogeneic cells. They 
found that, in cont rast to added syngeneic spleen cell s, LC 
syngeneic to responders could not restore t he CTL response. 
This was due in part to t he suppression of a llo-CTL induction 
via secretion of prostaglandin E by keratinocyt es. However, 
even when prostaglandin synt hesis was inhibi ted , LC were 
unable to restore the allo-CTL response in a cul ture system 
depleted of !a -bea ring adherent cells from the responder and 
stimulator cells. In addition, LC-enriched EC suspensions, 
which demonstrated functional enrichment for stimulatory 
functions, fa il ed to resto re t he CTL response in a trini t ro-
phenyl- (TNP) specific syngeneic CTL induction system [23). 
Steiner et a] [28] have a lso recently addressed t he question 
of restoration of a llo-CTL induction in an !a-posit ive adherent 
cell-dependent cul ture system and, in acco rd with T suchida et 
al, were unable to restore t he allo-CTL using fl at-bottomed 
cul t ure wells. However, t hey later used round bottom wells and 
cen trifuged the ce ll s in t he cul ture plates in order to enhance 
t he apposition of LC to the other cul tured cells. In addition 
t hey used indomethacin in order to prevent suppression induced 
by keratinocytes. Using t hese cul ture condi t ions Steiner et al 
[28] demonstrated t hat LC, which were syngeneic to responders 
could regu la rly presen t a llo class I ant ige ns to se lf T cells and 
t hereby generate CTL directed toward class I alloant ige n bea r-
ing target ce ll s. 
This in vit ro fi nding t hen presents us wi th a paradox since 
one would expect t hat if an organ, which was devoid of dendri t ic 
cells and t ransplanted in to a class I and class II histo incom-
patible host, were repopulated wi t h host dendri t ic cells, it would 
be rejected. The most likely reason that t his may not happen 
is that t he rec ipient becomes "tolerant" to t he donor tissue in 
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FI G 2. Effect of "panning" enrichment and depletion of mouse 
(C3H) LC on the ability of the EC suspensions to induce an allogeneic 
CTL response to BALB/c responder cells. In this case single epidermal 
cell suspensions (EC) were incubated for 60 min in Petri dishes which 
had been coated with anti Jak monoclonal antibody (10.2.16). The 
nonadherent cells (LC ! EC) were removed by gently swirling the 
plates. The adherent fractions were obtained after vigorous rinsing of 
the plates (LC i EC) . The percentage of LC in each suspension was 
EC = 2.5%, LC j EC = 20%, LC ! EC = 1.2%. Responder and stimulator 
spleen cells (SPL ) were passed through a Sephadex G10 column and 
then through a nylon wool column. 5 X 106 responder cells and 3 x 105 
allogeneic-stimulator cells were used per well of a 24-well Linbro culture 
plate. Effector cells generated after 5 days of cul ture were assayed using 
5 'Cr-labeled concanavalin A stimulated allogeneic spleen cell blasts as 
targets in a 4 h assay. Effector to target (E/ T) ratio is as noted in 
figure. 
the in te rval between transplantation and repopulation [29). In 
Faustman et a l's studies cited above, rejection of stable is let 
allografts prompt ly occurred when recipients were challenged 
with la rge numbers of dendrit ic cells 60 days after t ransplan -
tation. This antigen dose may have abrogated t he presumed 
tolerance or perhaps, but less likely, t here is no repopulation 
of donor islets wi th recipient dendri t ic cells. 
T aken together, t he data indicate that LC are effective 
ant igen-presenting cells in allogeneic and ant igen-specific T -
cell responses. The studies to date do not, however, address t he 
question as to how LC present antigen. IL-l like molecules, 
such as epidermal cell-derived t hymocyte activating factor 
(ETAF) , probably play an important role in the augmentation 
of some of t hese responses. The role of t hese facto rs is described 
elsewhere in t his symposium [30] . Al though it is clear t hat UV 
radiation abrogates, at least in pa rt, the ant igen-present ing 
function of LC, it may also a ffect ET AF production. Many of 
these questions a re now addressable because of t he advent of 
ant ige n-specific T -cell clones and T -cell hybridomas. 
Considerable knowledge has accumulated wit h regard to t he 
mechanism(s) by which present ing cells "process" and ul t i-
mately "present" antigen and thereby activate T cells. Studies 
from several laboratories have demonstrated t hat ant igen pres-
entation by macrophages (and B-cell tumor cells) can be inhib-
ited by chemicals which interfere wit h lysosomal t ransport and 
function [31- 35]. These studies indicate t hat large molecules 
such as ovalbumin, cytochrome, and myoglobin must be di -
gested so t hat t he smaller proteolytica lly cleaved molecules 
may t hen be "presented" to T cells. This chemical cleavage is 
necessary and sufficient to explain processing of soluble protein 
ant igen and its subsequent presentation by accessory cells. 
Using a battery of ovalbumin specific l -Ad restricted T -cell 
98s KATZ ET AL 
hybridomas, S himonkev itz et a l 135 ] demonstra ted t hat a 17-
residue peptide is capable of triggering severa l T -cell hybrido-
mas. That is, glu ta ra ldehyde- fi xed antigen -presenting ce ll s, 
which were ine ffective in presenting the intact ova lbumin toT 
cells, were able to present the immunogenic pept ide, thus 
bypassing t he lysomal "processing" step . Of importa nce to skin 
biologists is whether LC function as a ntige n-processing cells 
and t hereby "process" a nd prese nt. the appropriate immuno-
ge nic signa l. Alte rnatively, the keratinocyte may "process" the 
a ntige n a nd t he a pprop ria te cleaved fragment may be presented 
by LC. These quest ions a re currently under study. 
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